Nervous

XRPH partners with Molecular Science Signals creating a natural high for Crypto market, backed by USD Millions in research

Retrieved on: 
Tuesday, April 4, 2023

The pioneering organization has partnered with XRP Healthcare to develop a range of products utilizing molecular information to encourage natural wellness.

Key Points: 
  • The pioneering organization has partnered with XRP Healthcare to develop a range of products utilizing molecular information to encourage natural wellness.
  • One of the first products being brought to market fueled by XRPH and powered by Signals is CCC+C which stands for Cool, Calm, Collected + Crypto and is based on Resonant Molecular Signaling.
  • Cool, Calm, Collected + Crypto combines a low dose of specific molecules to stimulate the body's natural healing processes and restore balance.
  • Mental health disorders, such as depression, anxiety, and substance abuse, are prevalent in today's society and can have severe consequences if left untreated.

Interim review of proprietary PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the psilocybin arm versus the placebo arm in those participants who have completed the treatment

Retrieved on: 
Wednesday, March 15, 2023

MELBOURNE, Australia, March 15, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical cannabinoid and psychedelic medicines company, is pleased to announce results of an interim review of the conduct, safety and data from its ongoing Phase 2 clinical trial assessing its proprietary psilocybin-assisted psychotherapy program for Generalised Anxiety Disorder (‘GAD’), known as “PsiGAD”.

Key Points: 
  • An independent Data Safety Monitoring Board (DSMB) has reviewed data from Incannex’s ongoing Phase 2 “PsiGAD” clinical trial and recommends no changes to study design.
  • IHL has reviewed the interim data from the first 29 participants to complete the treatment protocol and completed a conditional power analysis using the interim data to model and project total study data.
  • The trial team have identified no safety concerns to date, and the DSMB has recommended that the trial continues without changes.
  • Treatment of all 72 trial participants is anticipated to be completed in the fourth quarter of 2023.

NEW GENESIS GV70 MARKETING CAMPAIGN INSPIRES TO 'KEEP BEGINNING'

Retrieved on: 
Tuesday, March 14, 2023

FOUNTAIN VALLEY, Calif., March 14, 2023 /PRNewswire/ -- Today, Genesis announced its new advertising campaign entitled "Keep Beginning" to introduce its first-ever Electrified GV70 to a new generation of consumers.

Key Points: 
  • FOUNTAIN VALLEY, Calif., March 14, 2023 /PRNewswire/ -- Today, Genesis announced its new advertising campaign entitled "Keep Beginning" to introduce its first-ever Electrified GV70 to a new generation of consumers.
  • Genesis strives to embolden and inspire new endeavors full of possibilities, because you're never done if you constantly keep beginning.
  • "The exhilaration of driving a GV70 is like experiencing something for the first time, every time, and that is core to the Genesis brand," said Wendy Orthman, executive director of marketing at Genesis Motor America.
  • The "Keep Beginning" marketing campaign was developed in collaboration with Genesis' agency of record, INNOCEAN USA, while its media agency, Canvas Worldwide, coordinated media placements.

Aiberry Secures $8M in Seed Funding to Accelerate AI-Powered Mental Health Screenings

Retrieved on: 
Wednesday, March 8, 2023

Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.

Key Points: 
  • Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.
  • (Photo: Business Wire)
    Mental health issues are widespread and growing rapidly.
  • “AI platforms such as Aiberry provide a wide range of benefits compared to traditional diagnostic methods,” said Lynne Dunbrack, Group Vice President for IDC Health Insights.
  • This allows organizations to easily determine which mental health resource is the best investment for their specific needs and goals.

Make Peace With Anxiety: New Supportiv Resources Provide Practical Tips And Recontextualize The Experience

Retrieved on: 
Friday, February 3, 2023

BERKELEY, Calif., Feb. 3, 2023 /PRNewswire-PRWeb/ -- Supportiv, the pioneer in Conversational Care™ and Precision Peer Support™, publishes today a new collection of anxiety resources, illustrating anxiety's many presentations, and supplementing anxiety-sufferers' paths toward relief.

Key Points: 
  • Anxiety can be a broad state of nervous system dysregulation , in which cause and effect are hard to untangle.
  • Cognitive, emotional, social, and circumstantial factors play off one another, to create an individual's unique experience of anxiety.
  • On the contrary, there are resources, strategies, and techniques that acknowledge the broader context of one's anxiety.
  • In addition to its peer-to-peer support network, relevant Supportiv articles and tips also surface in real-time inside its 24/7 peer support chats.

Babybel is Teaming up with Jason Biggs and Jenny Mollen to Create an Unforgettable 'First Time' Experience for the Vegan-Curious

Retrieved on: 
Thursday, February 2, 2023

CHICAGO, Feb. 2, 2023 /PRNewswire/ -- You never forget your first, which is why fan-favorite snack cheese brand Babybel® wants to make sure your first time trying plant-based cheese is with someone you trust. In partnership with married couple and actors Jason Biggs and Jenny Mollen, the brand is launching the Babybel 'First Time' Experience to support cheese-lovers as they lose their V-card (vegan card, that is).

Key Points: 
  • In partnership with married couple and actors Jason Biggs and Jenny Mollen, the brand is launching the Babybel 'First Time' Experience to support cheese-lovers as they lose their V-card (vegan card, that is).
  • Just in time for Valentine's Day, fans can enter to win their own Babybel 'First Time' Experience kit.
  • In the last year, plenty of vegan curious Babybel fans have experienced their own firsts, with Babybel Plant-Based more than doubling sales expectations.
  • ET, consumers can visit BabybelFirstTime2023.dja.com to enter the sweepstakes to win one of their very own Babybel 'First Time' Experience kits curated by Jason, Jenny and Babybel.

UK Gen Z Reports Feeling Impact of Cost-of-Living Crisis, but Almost All Confident in Their Future Home Ownership: Yubo

Retrieved on: 
Tuesday, December 13, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221213005177/en/
    The app finds itself in a unique position to understand this generation, as 99% of its userbase is Gen Z ages 13 to 25.
  • Almost nine in ten (87%) young Brits think theyll be able to afford a property in the future and three quarters (74%) are unconcerned about needing a degree.
  • Yubo is a live social discovery app making it easy for Gen Z to expand their social circles and hang out online with new friends from around the world.
  • Founded in France in 2015, Yubo today is used across more than 140 countries by over 60 million users.

Global Cool Gel Mattresses Market Report to 2027 - Growing Disposable Income of Consumers, Along With the Rise in Homeownership is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022

The global cool gel mattresses Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027.

Key Points: 
  • The global cool gel mattresses Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027.
  • As a result, the global cool mattresses market is estimated to grow at a rapid pace over the coming years.
  • Hotels are anticipated to hold a considerable share in the global cool gel mattresses market, as they change their mattresses more often than the residential users.
  • Besides this, the migrating population, which migrates to other cities and countries for study or job purposes, prefers acquitting cool gel mattresses for rent which is also adding to the growth of the Global cool gel mattresses market.

Holiday Season Can Be a Dangerous Time for Drug-Related Deaths

Retrieved on: 
Monday, November 28, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221128005421/en/
    A high-dose naloxone product could help families be prepared during the holiday season (Photo: Business Wire)
    At that moment, all my training kicked in, Pemberton said.
  • As we move into the holiday season, which sometimes brings stress and sadness, Pemberton knows it is essential, now more than ever, to have conversations and be prepared, as some people cope with substance use.
  • According to the Centers for Disease Control and Prevention , two of the most dangerous months for drug-and-alcohol-related deaths are December and January.
  • Statistics from the National Institute on Drug Abuse show opioid overdose deaths continue to increase annually, primarily with fentanyl.

NUCALM WILL UNLEASH THE POWER OF YOUR MENTAL STATE AT THE 2022 NEUROSCIENCE SUMMIT

Retrieved on: 
Tuesday, October 18, 2022

LOS ANGELES, Oct. 18, 2022 /PRNewswire/ -- NuCalm CEO Jim Poole will be this year's featured presenter at the 2022 Neuroscience Summit.

Key Points: 
  • LOS ANGELES, Oct. 18, 2022 /PRNewswire/ -- NuCalm CEO Jim Poole will be this year's featured presenter at the 2022 Neuroscience Summit.
  • The brain health and wellness event features a stellar lineup of New York Times Bestselling authors, Harvard scientists and mental health experts.
  • NuCalm research and their studies have led to a patented neuroscience technology unleashing the brain's unlimited potential.
  • NuCalm's unprecedented work in neuroscience gives individuals the power to improve memory, accelerate the learning process and most importantly the ability to harness calm.